What is the most recent earnings date for SLS stock?
SELLAS LIFE SCIENCES GROUP I (SLS) last reported earnings on 3/19/2026.
SELLAS LIFE SCIENCES GROUP I (SLS) Earnings History & Surprises
NASDAQ:SLS • US81642T2096
Current stock price
4.13 USD
-0.08 (-1.9%)
At close:
4.13 USD
0 (0%)
After Hours:
SLS Earnings overview
Past quarterly earnings results for SELLAS LIFE SCIENCES GROUP I (SLS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Mar 19, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.05
- EPS Surprise
- 23.84%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.05 | -0.07 | 23.84% | 37.50% | - | - | ||
| Q3 2025 | -0.06 | -0.07 | 9.99% | 40.00% | - | - | ||
| Q2 2025 | -0.07 | -0.08 | 15.82% | 46.15% | - | - | ||
| Q1 2025 | -0.07 | -0.11 | 33.99% | 66.67% | - | - | ||
| Q4 2024 | -0.08 | -0.11 | 26.20% | 68.00% | - | - | ||
| Q3 2024 | -0.10 | -0.13 | 23.84% | 69.70% | - | - | ||
| Q2 2024 | -0.13 | -0.17 | 21.99% | 58.06% | - | - | ||
| Q1 2024 | -0.21 | -0.16 | -29.95% | 55.32% | - | - | ||
| Q4 2023 | -0.25 | 0.00 | -8,900.90% | 41.86% | 13.13M | -100.00% | - | |
| Q3 2023 | -0.33 | 0.03 | -1,189.11% | 2.94% | 8.753M | -100.00% | - | |
| Q2 2023 | -0.31 | -0.36 | 13.54% | 24.39% | 3.283M | -100.00% | - | |
| Q1 2023 | -0.47 | -0.29 | -59.55% | 55.24% | - | -100.00% | ||
| Q4 2022 | -0.43 | -0.32 | -33.04% | -2.38% | - | - | ||
| Q3 2022 | -0.34 | -0.39 | 12.94% | 24.44% | - | - | ||
| Q2 2022 | -0.41 | -0.35 | -15.98% | -36.67% | - | -100.00% | ||
| Q1 2022 | -1.05 | -0.38 | -173.58% | -556.25% | 1M | - | -82.46% | |
| Q4 2021 | -0.42 | -0.41 | -1.42% | -50.00% | - | -100.00% | ||
| Q3 2021 | -0.45 | -0.38 | -18.29% | 15.09% | - | - | ||
| Q2 2021 | -0.30 | -0.39 | 23.84% | 54.55% | 1.9M | - | - | |
| Q1 2021 | -0.16 | -0.27 | 41.33% | 78.59% | 5.7M | - | - | |
| Q4 2020 | -0.28 | -0.28 | -0.81% | - | 1.9M | - | - | |
| Q3 2020 | -0.53 | -0.31 | -72.05% | - | - | - | ||
| Q2 2020 | -0.66 | -0.65 | -2.10% | - | - | - | ||
| Q1 2020 | -0.75 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
20.91%
Max EPS beat (4)
33.99%
Min EPS beat (4)
9.99%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, SLS has consistently beaten EPS estimates in all releases
In the last 4 quarters, SLS has beaten the EPS estimates by 20.9% on average.
Related analysis
SELLAS LIFE SCIENCES GROUP I / SLS Earnings FAQ
Can you provide information on whether SELLAS LIFE SCIENCES GROUP I beat earnings estimates in the last quarter?
SELLAS LIFE SCIENCES GROUP I (SLS) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often SELLAS LIFE SCIENCES GROUP I beats earnings estimates?
In the last 4 quarters, SELLAS LIFE SCIENCES GROUP I (SLS) has beaten EPS estimates in 4 out of 4 releases.